Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases.
Conclusions: In our population-based cohort, Y-90 was well-tolerated in patients with metastatic liver-dominant NETs. Prior surgical resection was an important predictor of OS.
PMID: 33299824 [PubMed - in process]
Source: Canadian Journal of Gastroenterology - Category: Gastroenterology Tags: Can J Gastroenterol Hepatol Source Type: research
More News: Brain | Canada Health | Cancer | Cancer & Oncology | Gastroenterology | Liver | Neurology | Neurosurgery | Pain | Pancreas | Pancreatic Cancer | Radiography | Toxicology | UK Health | Urology & Nephrology